Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxercalciferol in Postmenopausal Osteopenic Women
NCT07660536Phase 3Completed
- Sponsor
- Creighton University
- Start
- Nov 1989
- Primary completion
- Apr 1992
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Placebo with Doxercalciferol (2 arms). Primary endpoint: Bone Mineral Density at 24 months. Started Nov 1989; status: completed.
02
Drugs
doxercalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07660536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07660536.